ID   ACS2L_HUMAN             Reviewed;         689 AA.
AC   Q9NUB1; B3KXL2; B4DJZ3; D3DW48; F5H6F4; F8W7Y1; Q5TF42; Q8IV99;
AC   Q8N234; Q96JI1; Q96JX6; Q9NU28;
DT   23-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   23-APR-2003, sequence version 2.
DT   15-MAR-2017, entry version 142.
DE   RecName: Full=Acetyl-coenzyme A synthetase 2-like, mitochondrial;
DE            EC=6.2.1.1;
DE   AltName: Full=Acetate--CoA ligase 2;
DE   AltName: Full=Acetyl-CoA synthetase 2;
DE            Short=AceCS2;
DE   AltName: Full=Acyl-CoA synthetase short-chain family member 1;
DE   Flags: Precursor;
GN   Name=ACSS1; Synonyms=ACAS2L, KIAA1846;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 169-689 (ISOFORM 1), AND VARIANT
RP   MET-488.
RC   TISSUE=Placenta, Thalamus, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   MET-488.
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 336-689 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11347906; DOI=10.1093/dnares/8.2.85;
RA   Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XX.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 8:85-95(2001).
RN   [6]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [7]
RP   ACETYLATION AT LYS-642, MUTAGENESIS OF LYS-642, FUNCTION, ENZYME
RP   REGULATION, PROTEIN SEQUENCE OF N-TERMINUS, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=16788062; DOI=10.1073/pnas.0603968103;
RA   Schwer B., Bunkenborg J., Verdin R.O., Andersen J.S., Verdin E.;
RT   "Reversible lysine acetylation controls the activity of the
RT   mitochondrial enzyme acetyl-CoA synthetase 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10224-10229(2006).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-396, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 638-649 IN COMPLEX WITH
RP   SIRT3.
RX   PubMed=19535340; DOI=10.1074/jbc.M109.014928;
RA   Jin L., Wei W., Jiang Y., Peng H., Cai J., Mao C., Dai H., Choy W.,
RA   Bemis J.E., Jirousek M.R., Milne J.C., Westphal C.H., Perni R.B.;
RT   "Crystal structures of human SIRT3 displaying substrate-induced
RT   conformational changes.";
RL   J. Biol. Chem. 284:24394-24405(2009).
CC   -!- FUNCTION: Important for maintaining normal body temperature during
CC       fasting and for energy homeostasis. Essential for energy
CC       expenditure under ketogenic conditions (By similarity). Converts
CC       acetate to acetyl-CoA so that it can be used for oxidation through
CC       the tricarboxylic cycle to produce ATP and CO(2). {ECO:0000250,
CC       ECO:0000269|PubMed:16788062}.
CC   -!- CATALYTIC ACTIVITY: ATP + acetate + CoA = AMP + diphosphate +
CC       acetyl-CoA.
CC   -!- ENZYME REGULATION: Inhibited by acetylation at Lys-642 and
CC       activated by deacetylation. {ECO:0000269|PubMed:16788062}.
CC   -!- SUBUNIT: Interacts with SIRT3. {ECO:0000269|PubMed:19535340}.
CC   -!- INTERACTION:
CC       Q08AM6:VAC14; NbExp=5; IntAct=EBI-10313831, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:16788062}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9NUB1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NUB1-2; Sequence=VSP_007249;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9NUB1-3; Sequence=VSP_044693, VSP_044694;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9NUB1-4; Sequence=VSP_045546, VSP_045547;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Reversibly acetylated on Lys-642. The acetyl-CoA synthase
CC       activity is inhibited by acetylation and activated by
CC       deacetylation. {ECO:0000269|PubMed:16788062}.
CC   -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB55390.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC03853.1; Type=Frameshift; Positions=250; Evidence={ECO:0000305};
CC       Sequence=BAC03853.1; Type=Miscellaneous discrepancy; Note=Sequencing errors.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK027817; BAB55390.1; ALT_INIT; mRNA.
DR   EMBL; AK092295; BAC03853.1; ALT_SEQ; mRNA.
DR   EMBL; AK127566; BAG54524.1; -; mRNA.
DR   EMBL; AK296306; BAG59005.1; -; mRNA.
DR   EMBL; AL035661; CAI21828.1; -; Genomic_DNA.
DR   EMBL; AL080312; CAI21828.1; JOINED; Genomic_DNA.
DR   EMBL; AL080312; CAI18917.1; -; Genomic_DNA.
DR   EMBL; AL035661; CAI18917.1; JOINED; Genomic_DNA.
DR   EMBL; CH471133; EAX10106.1; -; Genomic_DNA.
DR   EMBL; CH471133; EAX10109.1; -; Genomic_DNA.
DR   EMBL; BC039261; AAH39261.1; -; mRNA.
DR   EMBL; BC044588; AAH44588.1; -; mRNA.
DR   EMBL; AB058749; BAB47475.1; -; mRNA.
DR   CCDS; CCDS13167.1; -. [Q9NUB1-1]
DR   CCDS; CCDS58764.1; -. [Q9NUB1-3]
DR   CCDS; CCDS58765.1; -. [Q9NUB1-4]
DR   RefSeq; NP_001239604.1; NM_001252675.1. [Q9NUB1-2]
DR   RefSeq; NP_001239605.1; NM_001252676.1. [Q9NUB1-3]
DR   RefSeq; NP_001239606.1; NM_001252677.1. [Q9NUB1-4]
DR   RefSeq; NP_115890.2; NM_032501.3. [Q9NUB1-1]
DR   UniGene; Hs.529353; -.
DR   PDB; 3GLR; X-ray; 1.80 A; B=638-649.
DR   PDB; 3GLT; X-ray; 2.10 A; B=638-649.
DR   PDB; 3GLU; X-ray; 2.50 A; B=638-649.
DR   PDB; 4BVE; X-ray; 2.05 A; B=638-647.
DR   PDB; 4BVF; X-ray; 2.70 A; B=638-647.
DR   PDB; 4BVG; X-ray; 2.50 A; B=638-647.
DR   PDB; 4C78; X-ray; 2.00 A; C=638-647.
DR   PDBsum; 3GLR; -.
DR   PDBsum; 3GLT; -.
DR   PDBsum; 3GLU; -.
DR   PDBsum; 4BVE; -.
DR   PDBsum; 4BVF; -.
DR   PDBsum; 4BVG; -.
DR   PDBsum; 4C78; -.
DR   ProteinModelPortal; Q9NUB1; -.
DR   SMR; Q9NUB1; -.
DR   BioGrid; 124122; 6.
DR   DIP; DIP-61208N; -.
DR   IntAct; Q9NUB1; 3.
DR   STRING; 9606.ENSP00000316924; -.
DR   DrugBank; DB00131; Adenosine monophosphate.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   SwissLipids; SLP:000000448; -.
DR   iPTMnet; Q9NUB1; -.
DR   PhosphoSitePlus; Q9NUB1; -.
DR   BioMuta; ACSS1; -.
DR   DMDM; 30172968; -.
DR   EPD; Q9NUB1; -.
DR   MaxQB; Q9NUB1; -.
DR   PaxDb; Q9NUB1; -.
DR   PeptideAtlas; Q9NUB1; -.
DR   PRIDE; Q9NUB1; -.
DR   Ensembl; ENST00000323482; ENSP00000316924; ENSG00000154930. [Q9NUB1-1]
DR   Ensembl; ENST00000432802; ENSP00000388793; ENSG00000154930. [Q9NUB1-4]
DR   Ensembl; ENST00000537502; ENSP00000439304; ENSG00000154930. [Q9NUB1-3]
DR   GeneID; 84532; -.
DR   KEGG; hsa:84532; -.
DR   UCSC; uc002wub.4; human. [Q9NUB1-1]
DR   CTD; 84532; -.
DR   DisGeNET; 84532; -.
DR   GeneCards; ACSS1; -.
DR   H-InvDB; HIX0015699; -.
DR   HGNC; HGNC:16091; ACSS1.
DR   HPA; HPA041014; -.
DR   HPA; HPA043228; -.
DR   MIM; 614355; gene.
DR   neXtProt; NX_Q9NUB1; -.
DR   OpenTargets; ENSG00000154930; -.
DR   PharmGKB; PA24430; -.
DR   eggNOG; KOG1175; Eukaryota.
DR   eggNOG; COG0365; LUCA.
DR   GeneTree; ENSGT00760000119178; -.
DR   HOVERGEN; HBG014401; -.
DR   InParanoid; Q9NUB1; -.
DR   KO; K01895; -.
DR   OMA; SSGKIGW; -.
DR   OrthoDB; EOG091G039C; -.
DR   PhylomeDB; Q9NUB1; -.
DR   TreeFam; TF354241; -.
DR   BRENDA; 6.2.1.1; 2681.
DR   Reactome; R-HSA-71384; Ethanol oxidation.
DR   ChiTaRS; ACSS1; human.
DR   EvolutionaryTrace; Q9NUB1; -.
DR   GenomeRNAi; 84532; -.
DR   PRO; PR:Q9NUB1; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000154930; -.
DR   CleanEx; HS_ACSS1; -.
DR   ExpressionAtlas; Q9NUB1; baseline and differential.
DR   Genevisible; Q9NUB1; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IDA:UniProtKB.
DR   GO; GO:0003987; F:acetate-CoA ligase activity; IDA:UniProtKB.
DR   GO; GO:0016208; F:AMP binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019413; P:acetate biosynthetic process; IEA:Ensembl.
DR   GO; GO:0006085; P:acetyl-CoA biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0019427; P:acetyl-CoA biosynthetic process from acetate; IEA:InterPro.
DR   GO; GO:0006069; P:ethanol oxidation; TAS:Reactome.
DR   GO; GO:0019542; P:propionate biosynthetic process; IEA:Ensembl.
DR   CDD; cd05966; ACS; 1.
DR   InterPro; IPR011904; Ac_CoA_lig.
DR   InterPro; IPR032387; ACAS_N.
DR   InterPro; IPR025110; AMP-bd_C.
DR   InterPro; IPR020845; AMP-binding_CS.
DR   InterPro; IPR000873; AMP-dep_Synth/Lig.
DR   Pfam; PF16177; ACAS_N; 1.
DR   Pfam; PF00501; AMP-binding; 1.
DR   Pfam; PF13193; AMP-binding_C; 1.
DR   TIGRFAMs; TIGR02188; Ac_CoA_lig_AcsA; 1.
DR   PROSITE; PS00455; AMP_BINDING; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Direct protein sequencing; Ligase; Mitochondrion;
KW   Nucleotide-binding; Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     37       Mitochondrion.
FT                                {ECO:0000269|PubMed:16788062}.
FT   CHAIN        38    689       Acetyl-coenzyme A synthetase 2-like,
FT                                mitochondrial.
FT                                /FTId=PRO_0000000596.
FT   NP_BIND     417    419       ATP. {ECO:0000250}.
FT   NP_BIND     441    446       ATP. {ECO:0000250}.
FT   REGION      224    227       Coenzyme A binding. {ECO:0000250}.
FT   COMPBIAS     45     53       Poly-Ala.
FT   BINDING     341    341       Coenzyme A. {ECO:0000250}.
FT   BINDING     533    533       ATP. {ECO:0000250}.
FT   BINDING     548    548       ATP. {ECO:0000250}.
FT   BINDING     556    556       Coenzyme A; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   BINDING     559    559       ATP. {ECO:0000250}.
FT   MOD_RES     396    396       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     642    642       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:16788062}.
FT   VAR_SEQ       1     22       MAARTLGRGVGRLLGSLRGLSG -> MRRRKERQPWDRFHF
FT                                LHFAPHG (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044693.
FT   VAR_SEQ      23    143       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044694.
FT   VAR_SEQ     446    447       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_007249.
FT   VAR_SEQ     556    575       SGHRLGTAEIEDAIADHPAV -> LQIVGFFREAIRNSGDL
FT                                LEH (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045546.
FT   VAR_SEQ     576    689       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045547.
FT   VARIANT     488    488       V -> M (in dbSNP:rs6050249).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_048184.
FT   MUTAGEN     642    642       K->Q: Loss of activity.
FT                                {ECO:0000269|PubMed:16788062}.
FT   CONFLICT    233    233       K -> I (in Ref. 1; BAG54524).
FT                                {ECO:0000305}.
FT   CONFLICT    277    277       V -> M (in Ref. 4; AAH39261).
FT                                {ECO:0000305}.
SQ   SEQUENCE   689 AA;  74857 MW;  66E84E39302AD08B CRC64;
     MAARTLGRGV GRLLGSLRGL SGQPARPPCG VSAPRRAASG PSGSAPAVAA AAAQPGSYPA
     LSAQAAREPA AFWGPLARDT LVWDTPYHTV WDCDFSTGKI GWFLGGQLNV SVNCLDQHVR
     KSPESVALIW ERDEPGTEVR ITYRELLETT CRLANTLKRH GVHRGDRVAI YMPVSPLAVA
     AMLACARIGA VHTVIFAGFS AESLAGRIND AKCKVVITFN QGLRGGRVVE LKKIVDEAVK
     HCPTVQHVLV AHRTDNKVHM GDLDVPLEQE MAKEDPVCAP ESMGSEDMLF MLYTSGSTGM
     PKGIVHTQAG YLLYAALTHK LVFDHQPGDI FGCVADIGWI TGHSYVVYGP LCNGATSVLF
     ESTPVYPNAG RYWETVERLK INQFYGAPTA VRLLLKYGDA WVKKYDRSSL RTLGSVGEPI
     NCEAWEWLHR VVGDSRCTLV DTWWQTETGG ICIAPRPSEE GAEILPAMAM RPFFGIVPVL
     MDEKGSVVEG SNVSGALCIS QAWPGMARTI YGDHQRFVDA YFKAYPGYYF TGDGAYRTEG
     GYYQITGRMD DVINISGHRL GTAEIEDAIA DHPAVPESAV IGYPHDIKGE AAFAFIVVKD
     SAGDSDVVVQ ELKSMVATKI AKYAVPDEIL VVKRLPKTRS GKVMRRLLRK IITSEAQELG
     DTTTLEDPSI IAEILSVYQK CKDKQAAAK
//
